All In MedTech

Device Trial Radar · NCT07347379

Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study

Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

108

Actual

Start

Nov 13, 2025

Primary completion

Aug 17, 2026

Study completion Sep 9, 2026

Sponsor

Lead sponsor
RxSight, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jan 16, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an observational, follow up study of subjects previously enrolled in the "RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) New Enrollment Study". The primary objective of this study is to collect long-term safety and effectiveness data on RxSight LAL in subjects previously implanted in the "RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) New Enrollment Study".

Conditions

  • Aphakia Cataract

Interventions

  • Light Adjustable lens (LAL) and Light Delivery Device (LDD)Device

    Experimental treatment group received Light adjustable lens with Light delivery Device treatments

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean absolute manifest refraction spherical equivalent (|MRSE|) at the Long-Term follow up visitTime frame: Up to 55 months
  2. Mean manifest cylinder at the Long-Term follow up visitTime frame: Up to 55 months

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Vance Thompson Vision

    Alexandria, Minnesota

  • Vance Thompson Vision

    Omaha, Nebraska

  • Key-Whitman Eye Center

    Dallas, Texas

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.